mesalamine has been researched along with Skin Diseases in 5 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
Excerpt | Relevance | Reference |
---|---|---|
" Mesalazine suppository was given to her for about 4 months, and glutamine capsules for 2 months, but the rectal ulcer remained unhealed." | 4.12 | Platelet-rich plasma for the treatment of chronic rectal ulcer: A case report. ( Ge, D; Li, P; Li, Y; Liu, G; Liu, J; Liu, Z; Wang, H; Wang, L; Zhao, G, 2022) |
"She was diagnosed with cutaneous polyarteritis nodosa (PAN) associated with CD." | 1.35 | Cutaneous polyarteritis nodosa in a patient with Crohn's disease. ( Kinoshita, K; Komatsuda, A; Maki, N; Masai, R; Niitsu, H; Ohtani, S; Sageshima, M; Sawada, K; Togashi, M; Wakui, H, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Liu, G | 1 |
Li, Y | 2 |
Wang, L | 1 |
Li, P | 1 |
Liu, Z | 1 |
Liu, J | 1 |
Ge, D | 1 |
Zhao, G | 1 |
Wang, H | 1 |
Komatsuda, A | 1 |
Kinoshita, K | 1 |
Togashi, M | 1 |
Maki, N | 1 |
Masai, R | 1 |
Niitsu, H | 1 |
Ohtani, S | 1 |
Sageshima, M | 1 |
Sawada, K | 1 |
Wakui, H | 1 |
Akbal, E | 1 |
Koçak, E | 1 |
Köklü, S | 1 |
Caprilli, R | 1 |
Gassull, MA | 1 |
Escher, JC | 1 |
Moser, G | 1 |
Munkholm, P | 1 |
Forbes, A | 1 |
Hommes, DW | 1 |
Lochs, H | 1 |
Angelucci, E | 1 |
Cocco, A | 1 |
Vucelic, B | 1 |
Hildebrand, H | 1 |
Kolacek, S | 1 |
Riis, L | 1 |
Lukas, M | 1 |
de Franchis, R | 1 |
Hamilton, M | 1 |
Jantschek, G | 1 |
Michetti, P | 1 |
O'Morain, C | 1 |
Anwar, MM | 1 |
Freitas, JL | 1 |
Mouzas, IA | 1 |
Baert, F | 1 |
Mitchell, R | 1 |
Hawkey, CJ | 1 |
Bamba, T | 1 |
Nishiyama, Y | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Synbiotic Treatment in Crohn's Disease Patients[NCT00305409] | 50 participants (Anticipated) | Interventional | 2006-06-30 | Completed | |||
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)[NCT04578392] | 181 participants (Anticipated) | Interventional | 2020-07-28 | Recruiting | |||
A Randomized, Controlled, Open-label Study to Assess the Efficacy of T2 Versus Azathioprine for the Maintenance of Clinical and Endoscopic Remission in Subjects With Crohn's Disease After Surgical Resection[NCT01015391] | 100 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for mesalamine and Skin Diseases
Article | Year |
---|---|
[Clinical features and management of the elderly patients with ulcerative colitis].
Topics: Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; | 1999 |
4 other studies available for mesalamine and Skin Diseases
Article | Year |
---|---|
Platelet-rich plasma for the treatment of chronic rectal ulcer: A case report.
Topics: Capsules; Colonic Diseases; Female; Glutamine; Humans; Mesalamine; Platelet-Rich Plasma; Rectal Dise | 2022 |
Cutaneous polyarteritis nodosa in a patient with Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Glucocort | 2008 |
Mesalamine (pentasa)-induced painful skin lesions.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Mesalamine; Prognosis | 2010 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |